Why the study?
Device-related thrombus following left atrial appendage occlusion is associated with embolic events, yet its optimal definition, incidence, risk factors, monitoring, therapy, and clinical outcomes remain open questions.
This review highlights the clinical importance, risk factors, and management of device-related thrombus following left atrial appendage occlusion, which occurs in 2-5% of cases.
Answers are grounded in this paper and cite their sources.
Device thrombus warrants clinical vigilance after LAAO; leaves open optimal prevention strategies.
Thrombus formation on intracardiac devices remains a subject of importance, with rates in the 2-5% range. Device-related thrombus (DRT) following left atrial appendage occlusion is an area of particular concern considering its association with embolic events. DRT continues to present numerous questions, including the optimal definition, incidence, risk factors, monitoring, therapy, and clinical outcomes - all subjects of ongoing assessment. Herein, we discuss these considerations, building upon the relevant historical context and pathophysiologic insights while discussing the future considerations in this rapidly evolving field.
No takes yet. Share an insight, caveat, or question.
Simard et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: